Real-time enrollment status for this alzheimer disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:37 AM UTC
| NCT Number | NCT06847321 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer Disease |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 39 sites in the US |
| Sponsor | Lighthouse Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT06847321 is currently recruiting participants. This clinical trial study for alzheimer disease is actively seeking new participants at 39 locations across the United States. The study is sponsored by Lighthouse Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06847321 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 39 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06847321 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.